MEDXF - Medexus Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
-10,922
-2,879
-28,264
-4,397
Depreciation & amortisation
6,111
6,145
5,978
3,706
Deferred income taxes
2,260
-941
-3,237
-790.4386
Stock-based compensation
1,084
1,883
1,270
1,385
Change in working capital
-12,483
4,730
182
-1,491
Accounts receivable
-5,828
4,430
-3,505
-7,258
Inventory
-6,639
-6,660
-9
997.0385
Other working capital
-3,375
-8,894
-5,717
-2,464
Other non-cash items
13,101
12,223
9,816
6,236
Net cash provided by operating activities
-1,525
-1,180
5,038
-1,622
Cash flows from investing activities
Investments in property, plant and equipment
-1,850
-7,714
-10,755
-841.9123
Acquisitions, net
-1,013
-482
-952
-27,935
Net cash used for investing activities
-2,863
-8,196
-11,704
-28,571
Cash flows from financing activities
Debt repayment
-204
-164
-369
-313.778
Common stock issued
-
0
22,635
0
Common stock repurchased
-
-
-
-2,636
Dividends paid
0
0
0
0
Other financing activities
-
-
-297
-342.6879
Net cash used provided by (used for) financing activities
4,267
663
18,683
14,602
Net change in cash
-121
-8,713
12,017
-15,592
Cash at beginning of period
9,571
18,704
5,233
20,593
Cash at end of period
9,450
10,018
18,704
5,235
Free cash flow
Operating cash flow
-1,525
-1,180
5,038
-1,622
Capital expenditure
-1,850
-7,714
-10,755
-841.9123
Free cash flow
-3,375
-8,894
-5,717
-2,464